Skip to main content

Table 2 Basic characteristics of patients who completed VascuQOL

From: Evaluation of vascular quality of life questionnaire in dialysis patients with peripheral arterial disease treated by low-density lipoprotein apheresis

 

Age

Gender

D

HD dur.

Fontaine stage

VascuQOL First LDL-A

VascuQOL Tenth LDL-A

VascuQOL One month

M

Non-CLI

68

Male

(−)

21

II

4.24

4.12

2.36

66

Male

(+)

14

II

5.36

5.28

5.44

74

Male

(+)

4

II

5.68

6.24

6.24

74

Male

(+)

6

II

5.44

5.6

5.84

73

Male

(+)

7

II

3.88

4

4

80

Male

(−)

5

II

2.36

2.88

2.56

51

Male

(−)

9

II

4.72

4.48

5.48

70

Male

(+)

1

II

5.72

5.88

5.36

73

Male

(+)

7

II

5.56

6.04

5.76

63

Male

(+)

20

II

1.64

3.04

2.96

68

Female

(+)

12

II

4.6

5.36

5.52

68

Male

(+)

1

II

5.92

5.4

5.48

78

Male

(−)

22

II

5.84

5.88

5.44

70

Male

(+)

1

II

6.04

6.24

6.48

CLI

76

Male

(+)

2

III

2.68

2.92

3.28

57

Male

(+)

7

IV

2.64

4.6

4.16

67

Male

(+)

12

III

3.36

2.52

3.64

72

Female

(+)

9

III

1.92

1.8

2.84

81

Male

(+)

1

III

2.24

3.04

3.72

67

Female

(+)

16

III

3.36

3.48

3.64

70

Male

(+)

21

IV

6.04

6.64

6.76

64

Female

(+)

1

IV

5.28

4.76

5.16

  1. HD dur. HD duration (years). One month 1 month after completion of LDL-A treatment